EFM
BEAM icon

E Fund Management’s Beam Therapeutics BEAM Stock Holding History

E Fund Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$453K Sell
13,199
-8,541
-39% -$258K 0.01% 296
2026
Q1 		$518K Buy
+21,740
New +$603K 0.02% 286
2025
Q2 		$233K Buy
13,675
+2,472
+22% +$43K 0.01% 344
2025
Q1 		$219K Buy
+11,203
New +$293K 0.01% 350
2024
Q4 		– Sell
-12,020
Closed -$294K – 400
2024
Q3 		$294K Buy
12,020
+1,983
+20% +$51.2K 0.02% 264
2024
Q2 		$235K Sell
10,037
-1,510
-13% -$37.1K 0.01% 265
2024
Q1 		$382K Sell
11,547
-6,627
-36% -$206K 0.02% 232
2023
Q4 		$495K Buy
18,174
+704
+4% +$17.5K 0.03% 171
2023
Q3 		$420K Buy
17,470
+3,603
+26% +$96.6K 0.03% 159
2023
Q2 		$443K Buy
13,867
+1,851
+15% +$60.1K 0.04% 138
2023
Q1 		$368K Buy
12,016
+1,981
+20% +$78.2K 0.03% 196
2022
Q4 		$392K Buy
10,035
+1,752
+21% +$78.5K 0.03% 185
2022
Q3 		$395K Sell
8,283
-4,954
-37% -$283K 0.04% 185
2022
Q2 		$512K Buy
13,237
+8,833
+201% +$351K 0.05% 137
2022
Q1 		$252K Buy
+4,404
New +$289K 0.01% 255

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

E Fund Management's BEAM Position: Q2 2026 in Review

E Fund Management reduced its Beam Therapeutics (BEAM) stake by 39% in Q2 2026, selling an estimated $258K and leaving 13,199 shares worth $453K. The position accounts for 0.01% of the portfolio, ranked #296.

E Fund Management first reported a position in BEAM in Q1 2022 and has held it in 15 quarters since. The position peaked at $518K in Q1 2026. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • E Fund Management held 13,199 shares of Beam Therapeutics worth $453K as of Q2 2026.
  • E Fund Management sold 8,541 Beam Therapeutics shares in Q2 2026, an estimated $258K.
  • Beam Therapeutics made up 0.01% of E Fund Management's portfolio in Q2 2026, its #296 holding.
  • E Fund Management first reported a position in Beam Therapeutics in Q1 2022 and has held it in 15 quarters since.
  • E Fund Management's Beam Therapeutics position peaked at $518K in Q1 2026.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.